By the end of this activity, participants will be able to analyze recent head-to-head clinical trials in IBD, apply the latest evidence on mucosal healing, neoplasia surveillance, and combination therapies, understand new medical treatments and their impact on IBD care, recognize the multi-disciplinary team's role in managing IBD, and review the efficacy and safety of biosimilars in IBD. |